G6PDi-1
G6PDi-1 is a reversible and non-competitive glucose-6-phosphate dehydrogenase (G6PD) inhibitor with an IC50 of 0.07 μM for human G6PD. G6PDi-1 depletes NADPH most strongly in lymphocytes. G6PDi-1 markedly decreases inflammatory cytokine production in T cells[1].
Product Specifications
CAS Number
2457232-14-1
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
PDI
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/g6pdi-1.html
Purity
99.53
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
N#CC1=CC(NC2=NC=C(C(CCCC3)=O)C3=N2)=CS1
Molecular Formula
C14H12N4OS
Molecular Weight
284.34
Precautions
H302, H315, H319, H335
References & Citations
[1]Jonathan M Ghergurovich, et al. A small molecule G6PD inhibitor reveals immune dependence on pentose phosphate pathway. Nat Chem Biol. 2020 Jul;16 (7) :731-739.|[2]Watermann P, et al. G6PDi-1 is a Potent Inhibitor of G6PDH and of Pentose Phosphate pathway-dependent Metabolic Processes in Cultured Primary Astrocytes. Neurochem Res. 2023 Oct;48 (10) :3177-3189.|[3]Ding H, et al. Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition. Sci Adv. 2021 Nov 19;7 (47) :eabk1023.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6432897-01 0.1 mL
PRKAB2 (5'-AMP-activated Protein Kinase Subunit beta-2, AMPK Subunit beta-2) (PE)
Sign In for Pricing
View Details MBS6432897-02 5x 0.1 mL
PRKAB2 (5'-AMP-activated Protein Kinase Subunit beta-2, AMPK Subunit beta-2) (PE)
Sign In for Pricing
View Details 